Veterinary Pathology · 2001 · 68 citations · 18 references
MedicineOncologyPathologyNeoplasiaNeuro-oncologyOncogenesMalignant TumorsMolecular Classification Of TumorsNervous System PathologyPeripheral Nerve TumorsTumor ClassificationTumor MorphologyGenetic Marker DiscoveryNerve Sheath Tumor PathologyPeripheral Nerve Tumor DiagnosisPeripheral Nerve Tumor Genetic ProfilingPeripheral Nerve Tumor HistopathologyPoint Mutation AnalysisProto-oncogene MutationSchwann Cell Pathology
Thirty-four peripheral nerve sheath tumors of four domesticated animal species were characterized and assayed for point mutation of the neu oncogene. Based on their morphoimmunophenotype, 32 tumors were classified as schwannomas. Schwannoma morphology was characterized by the presence of Antoni type A and B pattern and immunoreactivity for S-100 protein and vimentin. Two anaplastic and metastatic tumors originating from spinal cord root, immunonegative for S-100 protein and positive for vimentin, were classified as malignant peripheral nerve sheath tumors (MPNSTs). Four malignant schwannomas and two MPNSTs expressed a point mutation of the neu oncogene by the polymerase chain reaction-restriction fragment length polymorphism method. The finding of neu oncogene mutation could be a useful diagnostic genetic marker in the malignant form of peripheral nerve sheath tumors in animals.
18
&NA; · Journal of Neuropathology & Experimental Neurology · 1995 · 646 citations · Full text
Intracranial parenchymal schwannoma
Gian Piero Casadei, Takashi Komori, Bernd W. Scheithauer et al. · Journal of neurosurgery · 1993 · 129 citations
Medicine, Neurosurgery, Oncology +15
Malignant Epithelioid Schwannoma Affecting the Trigeminal Nerve of a Dog
Martı́ Pumarola, Sònia Añor, D. Borràs et al. · Veterinary Pathology · 1996 · 52 citations · Full text